Published 2018 | Version Accepted Version
Journal Article Open

Methods for the Detection, Study, and Dynamic Profiling of O-GlcNAc Glycosylation

Abstract

The addition of O-linked β-N-acetylglucosamine (O-GlcNAc) to serine/threonine residues of proteins is a ubiquitous posttranslational modification found in all multicellular organisms. Like phosphorylation, O-GlcNAc glycosylation (O-GlcNAcylation) is inducible and regulates a myriad of physiological and pathological processes. However, understanding the diverse functions of O-GlcNAcylation is often challenging due to the difficulty of detecting and quantifying the modification. Thus, robust methods to study O-GlcNAcylation are essential to elucidate its key roles in the regulation of individual proteins, complex cellular processes, and disease. In this chapter, we describe a set of chemoenzymatic labeling methods to (1) detect O-GlcNAcylation on proteins of interest, (2) monitor changes in both the total levels of O-GlcNAcylation and its stoichiometry on proteins of interest, and (3) enable mapping of O-GlcNAc to specific serine/threonine residues within proteins to facilitate functional studies. First, we outline a procedure for the expression and purification of a multiuse mutant galactosyltransferase enzyme (Y289L GalT). We then describe the use of Y289L GalT to modify O-GlcNAc residues with a functional handle, N-azidoacetylgalactosamine (GalNAz). Finally, we discuss several applications of the copper-catalyzed azide-alkyne cycloaddition "click" reaction to attach various alkyne-containing chemical probes to GalNAz and demonstrate how this functionalization of O-GlcNAc-modified proteins can be used to realize (1)–(3) above. Overall, these methods, which utilize commercially available reagents and standard protein analytical tools, will serve to advance our understanding of the diverse and important functions of O-GlcNAcylation.

Additional Information

© 2018 Elsevier Inc. Available online 7 August 2017. This work was supported by the National Institutes of General Medical Sciences (NIGMS) grant R01-GM084724 (L.C.H.-W.), NIGMS training grants T32-GM008042 and T32-GM07616 (J.W.T.), the UCLA-Caltech Medical Scientist Training Program ( J.W.T.), and the National Science Foundation Graduate Research Fellowship DGE-1144469 (M.E.G.). We thank Dr. P. Qasba (National Cancer Institute at Frederick) for generously providing the Y289L GalT construct and Dr. M. Shahgholi (Caltech CCE Multiuser Mass Spectrometry Laboratory) for assistance with MALDI-TOF MS analysis of O-GlcNAcylated peptides. We also thank Drs. E. Peters and D. Mason (Genomics Research Institute of the Novartis Research Foundation) for their suggestions, feedback, and critical discussions about O-GlcNAc site mapping.

Attached Files

Accepted Version - nihms943751.pdf

Files

nihms943751.pdf

Files (617.8 kB)

Name Size
md5:ddd285ef418f3538626c8ef0ba4a60ad
617.8 kB Preview Download

Additional details

Identifiers

PMCID
PMC5886303
Eprint ID
84327
DOI
10.1016/bs.mie.2017.06.009
Resolver ID
CaltechAUTHORS:20180116-090624906

Related works

Funding

NIH
R01-GM084724
NIH Predoctoral Fellowship
T32-GM008042
NIH Predoctoral Fellowship
T32-GM07616-04
NSF Graduate Research Fellowship
DGE-1144469

Dates

Created
2018-01-17
Created from EPrint's datestamp field
Updated
2021-11-15
Created from EPrint's last_modified field